Literature DB >> 27899554

Biotin supplementation in MS clinically valuable but can alter multiple blood test results.

Ursela Siddiqui1, Emily Egnor1, Jacob A Sloane1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27899554     DOI： 10.1177/1352458516680751

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  5 in total

1.  The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis.

Authors:  Carolyn H Goldschmidt; Jeffrey A Cohen
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 7.620

2.  Biotin interference: Underrecognized patient safety risk in laboratory testing.

Authors:  Jessica L Gifford; S M Hossein Sadrzadeh; Christopher Naugler
Journal:  Can Fam Physician       Date:  2018-05       Impact factor: 3.275

3.  Biotin supplements and laboratory test results in neuropsychiatric practice and research.

Authors:  T S Sathyanarayana Rao; Rita Christopher; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2017 Oct-Dec       Impact factor: 1.759

4.  Analytical evaluation of the Radiometer AQT90 FLEX βhCG assay.

Authors:  Miranda M Brun; Laura Holloway; Amanda Oleksy; Jan Dayton; Mathew P Estey; Bobbi-Lynn Goudreau; Anna K Füzéry
Journal:  Pract Lab Med       Date:  2019-01-11

Review 5.  Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis.

Authors:  Rebecca M Heidker; Mitchell R Emerson; Steven M LeVine
Journal:  Neural Regen Res       Date:  2017-08       Impact factor: 5.135
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.